Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat [Phase 4]

View source ↗

Summary

Phase 4 trial update examining testosterone in HIV-positive men with low testosterone and abdominal fat.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 4 | Status: COMPLETED